Fidelity Funds - Sustainable Europe Equity Fund D-Acc-EURRegister to Unlock Ratings |
Performance History | 31/10/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | -12.2 | 9.1 | 6.0 | |||
+/-Cat | -3.9 | -2.4 | 2.2 | |||
+/-B’mrk | -7.6 | -4.1 | 0.5 | |||
Morningstar Restructure Date: 28/10/2021 | ||||||
Category: Europe Large-Cap Blend Equity | ||||||
Category Benchmark: Morningstar DM Eur TME NR EUR | ||||||
Effective 28/10/2021, this fund's investment strategy changed to the extent that its record prior to that date is not relevant to its new format. Performance prior to that date is not shown. |
Key Stats | ||
NAV 21/11/2024 | EUR 13.52 | |
Day Change | 0.78% | |
Morningstar Category™ | Europe Large-Cap Blend Equity | |
ISIN | LU1387833087 | |
Fund Size (Mil) 31/10/2024 | EUR 209.52 | |
Share Class Size (Mil) 21/11/2024 | EUR 0.24 | |
Max Initial Charge | 4.00% | |
Ongoing Charge 17/02/2023 | 2.42% |
Investment Objective: Fidelity Funds - Sustainable Europe Equity Fund D-Acc-EUR |
The fund aims to achieve capital growth over the long term. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Terry Raven 01/08/2019 | ||
Alexander Grant 28/10/2021 | ||
Inception Date 15/04/2016 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI Europe NR EUR | Morningstar DM Eur TME NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Fidelity Funds - Sustainable Europe Equity Fund D-Acc-EUR | 30/09/2024 |
|
|
Top 5 Holdings | Sector | % |
ASML Holding NV | Technology | 5.45 |
AstraZeneca PLC | Healthcare | 4.43 |
Novo Nordisk AS Class B | Healthcare | 4.18 |
Unilever PLC | Consumer Defensive | 3.63 |
RELX PLC | Industrials | 3.58 |
Increase Decrease New since last portfolio | ||
Fidelity Funds - Sustainable Europe Equity Fund D-Acc-EUR |